Lasertherapy for Vulvodynia

Launched by MEDICAL UNIVERSITY OF GRAZ · Jan 12, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called laser therapy for women suffering from vulvodynia, a condition that causes chronic pain in the vulvar area. The goal is to see how effective this therapy is, how well women accept it, and whether it is safe for use. The study is currently looking for participants, specifically women aged between 18 and 65 who have been diagnosed with vulvodynia and have tried other treatments for at least three months.

To join the trial, participants should not have any current genital infections or certain skin conditions affecting the vulva, and they should not be pregnant or have had recent trauma to the area. Those who qualify can expect to undergo laser therapy and will be monitored for its effectiveness and any side effects. This trial is an important step in finding new ways to help women with vulvodynia find relief from their pain.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women with vulvodynia (diagnosed according to the 2015 Consensus Terminology)
• • multidisciplinary treatment for at least 3 months
• • Informed consent
• Exclusion Criteria:
• • Current genital infection (i.e. candidiasis, herpes )
• • Inflammatory vulvar disease/ dermatosis (i.e. lichen sclerosus, lichen planus)
• • Neoplastic vulvar disease (e.g. HSIL Vulva, Paget disease)
• • Recent vulvar trauma (i.e. bleeding, erosion or ulceration)
• • Pudendal neuralgia
• • Pregnancy, delivery \<6 months
• • Epilepsy or major neurologic or psychiatric morbidity
• • Active systemic infection
• • Previous treatment with ionizing radiation in the area to be treated
• • History of wound healing disorders (i.e. hyperpigmentation, abnormal scarring)
• • Fever
• • Systemic or local autoimmune disorders
• • History of photosensitivity disorder